This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Jan;8(1):e4-e6.

doi: 10.1016/S2352-3026(20)30361-6. Epub 2020 Dec 22.

High-risk myeloma: a challenge to define and to determine the optimal treatment

Charlotte Pawlyn¹

Affiliations

PMID: 33357481
DOI: 10.1016/S2352-3026(20)30361-6

Comment

High-risk myeloma: a challenge to define and to determine the optimal treatment

Charlotte Pawlyn. Lancet Haematol. 2021 Jan.

. 2021 Jan;8(1):e4-e6.

doi: 10.1016/S2352-3026(20)30361-6. Epub 2020 Dec 22.

Author

Charlotte Pawlyn¹

Affiliation

¹ The Institue of Cancer Research, London, UK; The Royal Marsen Hospital NHS Foundation Trust, London, UK. Electronic address: charlotte.pawlyn@icr.ac.uk.

PMID: 33357481
DOI: 10.1016/S2352-3026(20)30361-6

No abstract available

PubMed Disclaimer

Comment on

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial.
Usmani SZ, Hoering A, Ailawadhi S, Sexton R, Lipe B, Hita SF, Valent J, Rosenzweig M, Zonder JA, Dhodapkar M, Callander N, Zimmerman T, Voorhees PM, Durie B, Rajkumar SV, Richardson PG, Orlowski RZ; SWOG1211 Trial Investigators. Usmani SZ, et al. Lancet Haematol. 2021 Jan;8(1):e45-e54. doi: 10.1016/S2352-3026(20)30354-9. Epub 2020 Dec 22. Lancet Haematol. 2021. PMID: 33357482 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov

Grants and funding

29957/CRUK_/Cancer Research UK/United Kingdom

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information